Male Reproduction and Aging.
Androgen deficiency
Late-onset hypogonadism
Testosterone replacement therapy
Journal
Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
entrez:
22
3
2023
pubmed:
23
3
2023
medline:
25
3
2023
Statut:
ppublish
Résumé
Recent publications of well-conducted population studies have informed us that the syndromic prevalence of age-related low testosterone, also known as late-onset hypogonadism, is quite low. Several well-conducted trials in middle-aged and older men with age-related decline in testosterone levels have revealed that efficacy of testosterone therapy is modest with improvement in sexual function, mood, volumetric bone density, and anemia. Although select older men might benefit from testosterone therapy, its effect on prostate cancer risk and major adverse cardiovascular events remains unclear. The results of the ongoing TRAVERSE trial will likely provide important insights into these risks.
Identifiants
pubmed: 36948776
pii: S0889-8529(22)00121-9
doi: 10.1016/j.ecl.2022.12.002
pii:
doi:
Substances chimiques
Testosterone
3XMK78S47O
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
211-228Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.